In chronological order of occurrence:
TeraRecon refreshes clinical AI platform to support algorithms developed by TeraRecon clients, third parties and the company itself while enabling a single unified workflow (Oct. 20). Wake Radiology CIO Matt Dewey: “We are excited with the [next-generation] platform and its capabilities in executing third party AI algorithms, such as InferVision’s InferRead CT Lung AI. … This has led to efficient readings for our radiologists, reducing the time it takes to review lung CT.”
Vanderbilt University Medical Center spinoff Nashville Biosciences adds de-identified medical images and corresponding radiology reports to clinical phenotype offerings for client research and development teams (Oct. 24). Company founder and CEO Leeland Ekstrom: “One of the strengths we bring to our clients’ R&D efforts is the depth of clinical phenotype data from VU Medical Center’s EMR. Adding de-identified radiologic images increases that depth and provides an exciting new analytic dimension to our offerings.”
United Imaging Healthcare of Shanghai debuts whole-body PET/CT scanner developed with the University of California, Davis (Oct. 24). UIH executive Li Hongdi: “As nuclear medicine and molecular imaging equipment is becoming more and more complex, we believe it is time to collaborate between industry and academia to quickly find tailored, precise solutions and bring the value of molecular imaging to oncology, cardiology and neuroscience for high quality patient care.”
With an eye on eventually reaching healthcare AI markets across the Middle East, Seoul-based Lunit partners with Abu Dhabi Health Services Company (SEHA) to validate Lunit’s radiological AI on chest X-rays and mammography exams at the largest healthcare network in the United Arab Emirates (Oct. 24). SEHA radiologist Dr. Afra Rashed Saeed Almesaied Alneyadi: “[W]e will work with Lunit to implement Korea’s world-class medical AI imaging solution during proof-of-concept experiments. Our goal is to provide better medical services to our patients by improving SEHA’s medical image analysis program.”
Brainlab subsidiary Mint Medical of Munich, Germany, works with the German Society for Orthopedics and Orthopedic Surgery to build dynamic data registries through a society nonprofit, RSG Register Solutions (Oct. 24). Brainlab president and CEO Stefan Vilsmeier: “The RSG data trust center … now allows us to collect healthcare data across clinics in a structured and secure manner. By making this technology available to as many healthcare stakeholders as possible, we can contribute to better patient care in an aging society.”
Clarius Mobile Health of Vancouver, B.C., opens Clarius Marketplace, a platform for ultrasound AI developers working with Clarius wireless scanners to speed their time to market (Oct. 25). Clarius founder and CIO Laurent Pelissier: “We live in a world where new Apps that make our lives easier pop up every day on the App Store and Google Play. Our open platform and Clarius Marketplace will enable a similar proliferation of innovation in the ultrasound space that will ultimately improve access to medical imaging for patients.”
Medical imaging IT supplier Sectra closes sale of digital pathology software and service to three university hospitals in France (Oct. 26). Pathologist Dr. O. Renaud of Poitiers University Hospital: “Remote access to pathology cases will enable us to share and leverage resources between our hospitals and to facilitate the management of complex cases requiring special expertise [and] also to foster teaching and research activities. It will also allow us to offer our pathologists, if they wish, a more flexible life thanks to remote work.”
Vida Diagnostics (Coralville, Iowa) partners with Rayus Radiology (Minneapolis) to set up more than 150 locations as clinical trial imaging sites (Oct. 26). Vida president and CEO Susan Wood, PhD: “Together we are addressing a major gap in the still too costly, inefficient and time-consuming drug development process—site location and convenience to patients, trial site capacity, consistency and effectiveness. This partnership will help bridge the gap and accelerate new life-enhancing therapies for patients.”
NorthStar Medical Radioisotopes (Beloit, Wis.) supplying Radiopharm Theranostics (Sydney, Australia) with Actinium-225 to support drug trials involving targeted nuc-med therapy in multiple disease areas (Oct. 26). NorthStar CEO Stephen Merrick: “We look forward to [bringing] Actinium-225 to the team at Radiopharm Theranostics with the aim of together making a difference, to develop revolutionary, environmentally preferable therapeutic radiopharmaceuticals that have enormous potential to benefit patients with serious disease.”
Radiotherapy equipment service firm RS&A (Rural Hall, N.C.) acquires ultrasound and mammography servicer Summit Imaging of Woodinville, Wash. (Oct. 26).
Samsung subsidiary Boston Imaging introduces FDA-approved, glass-free X-ray detector (Oct. 27).
RaySearch Laboratories of Stockholm, Sweden, installing proton therapy planning system at McLaren Proton Therapy Center in Flint, Mich. (Oct. 28).
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.